JCI - Citations to Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

Citations to this article

Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

P N Hawkins, … , R Wootton, M B Pepys

P N Hawkins, … , R Wootton, M B Pepys

Published December 1, 1990
Citation Information: J Clin Invest. 1990;86(6):1862-1869. https://doi.org/10.1172/JCI114917.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2021	2019	2018	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1988	Total
Citations:	1	1	1	4	2	1	5	2	2	1	3	1	1	1	2	1	2	5	2	4	2	2	3	1	5	7	5	3	3	1	74

Citation information

Citations to this article (74)

Title and authors	Publication	Year
A New Era for PET/CT: Applications in Non-Tumorous Renal Pathologies Moghrabi S, Abdlkadir AS, Al-Hajaj N, Gnanasegaran G, Kumar R, Syed G, Bozkurt MF, Shukri S, Obeidat S, Khalaf A, Shahait M, Al-Nabhani K, Al-Ibraheem A	Journal of Clinical Medicine	2024
Increased levels of pentraxins protein and cytokines bear good association in patients with severe dengue infection G Patra, B Saha, S Mukhopadhyay	Scientific Reports	2021
Cardiac amyloidosis A Giorgetti, D Genovesi, E Milan, W Acampa, R Giubbini, A Cuocolo, P Marzullo	Clinical and Translational Imaging	2019
The Development of Serum Amyloid P as a Possible Therapeutic D Pilling, RH Gomer	Frontiers in immunology	2018
Pentraxins CRP-I and CRP-II are post-translationally deiminated and differ in tissue specificity in cod (Gadus morhua L.) ontogeny B Magnadóttir, P Hayes, B Gísladóttir, BÞ Bragason, M Hristova, AP Nicholas, S Guðmundsdóttir, S Lange	Developmental and comparative immunology	2018
The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs MB Pepys	Frontiers in immunology	2018
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects H Ino, Y Doi, L Liefaard, L Cookson, C Chen, H Itoh, H Igarashi, A Nakano	Clinical Pharmacology in Drug Development	2018
Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis: Target Mediated Drug Disposition Model of CPHPC T Sahota, A Berges, S Barton, L Cookson, S Zamuner, D Richards	The Journal of Pathology	2015
Amyloid persistence in decellularized liver: biochemical and histopathological characterization G Mazza, JP Simons, R Al-Shawi, S Ellmerich, L Urbani, S Giorgetti, GW Taylor, JA Gilbertson, AR Hall, W Al-Akkad, D Dhar, PN Hawkins, PD Coppi, M Pinzani, V Bellotti, PP Mangione	Amyloid	2015
Nuclear imaging of amyloidosis W Cytawa, J Teodorczyk, P Lass	Polish Journal of Radiology	2014
Imaging in systemic amyloidosis S Sachchithanantham, AD Wechalekar	British Medical Bulletin	2013
Pathogenetic mechanisms of amyloid A amyloidosis JP Simons, R Al-Shawi, S Ellmerich, I Speck, S Aslam, WL Hutchinson, PP Mangione, P Disterer, JA Gilbertson, T Hunt, DJ Millar, S Minogue, K Bodin, MB Pepys, PN Hawkins	Proceedings of the National Academy of Sciences	2013
Diagnosis of amyloidosis and differentiation from chronic, idiopathic enterocolitis in rhesus (Macaca mulatta) and pig-tailed (M. nemestrina) macaques KA Rice, ES Chen, KA Pate, EK Hutchinson, RJ Adams	Comparative medicine	2013
Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging R Minamimoto, K Kubota, K Ishii, M Morooka, M Okasaki, Y Miyata, K Nakajima, T Sato, T Igari, R Hirai, O Okazaki	American journal of nuclear medicine and molecular imaging	2013
Re-evaluating the potentials and limitations of 99mTc-aprotinin scintigraphy for amyloid imaging R Minamimoto, K Kubota, K Ishii, M Morooka, M Okasaki, Y Miyata, K Nakajima, T Sato, T Igari, R Hirai, O Okazaki	American journal of nuclear medicine and molecular imaging	2013
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use MB Pepys, JR Gallimore, J Lloyd, Z Li, D Graham, GW Taylor, S Ellmerich, PP Mangione, GA Tennent, WL Hutchinson, DJ Millar, G Bennett, J More, D Evans, Y Mistry, S Poole, PN Hawkins	Journal of Immunological Methods	2012
AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils JS Wall, SJ Kennel, A Williams, T Richey, A Stuckey, Y Huang, S Macy, R Donnell, R Barbour, P Seubert, D Schenk, P Westermark	PloS one	2012
Macrophage Differentiation and Polarization via Phosphatidylinositol 3-Kinase/Akt–ERK Signaling Pathway Conferred by Serum Amyloid P Component W Zhang, W Xu, S Xiong	Journal of immunology (Baltimore, Md. : 1950)	2011
Avances en el tratamiento de la amiloidosis F Martínez-Valle, M Gironella-Mesa, R Solans-Laqué	Medicina Clínica	2011
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis JD Gillmore, GA Tennent, WL Hutchinson, JR Gallimore, HJ Lachmann, HJ Goodman, M Offer, DJ Millar, A Petrie, PN Hawkins, MB Pepys	British Journal of Haematology	2010
Serologic evaluation of clinical and subclinical secondary hepatic amyloidosis in rhesus macaques (Macaca mulatta) JG MacGuire, KL Christe, JA Yee, AL Kalman-Bowlus, NW Lerche	Comparative medicine	2009
Target Pattern Recognition in Innate Immunity U Kishore		2009
Pattern recognition by pentraxins. Agrawal A, Singh PP, Bottazzi B, Garlanda C, Mantovani A	Advances in experimental medicine and biology	2009
Novartis Foundation Symposia EJ Campbell	Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction	2008
Normal circulating serum amyloid P component concentration in systemic sclerosis GA Tennent, M Dziadzio, E Triantafillidou, P Davies, JR Gallimore, CP Denton, MB Pepys	Arthritis & Rheumatism	2007
Diagnostic Performance of 123I-Labeled Serum Amyloid P Component Scintigraphy in Patients with Amyloidosis BP Hazenberg, MH van Rijswijk, DA Piers, MN Hooge, E Vellenga, EB Haagsma, PN Hawkins, PL Jager	The American Journal of Medicine	2006
Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro Z Urbányi, E Forrai, M Sárvári, I Likó, J Illés, T Pázmány	Neurochemistry International	2005
Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis JS Wall, SJ Kennel, MJ Paulus, S Gleason, J Gregor, J Baba, M Schell, T Richey, B O'nuallain, R Donnell, PN Hawkins, DT Weiss, A Solomon	Amyloid	2005
Serum amyloid P component in mink, a non-glycosylated protein with affinity for phosphorylethanolamine and phosphorylcholine LA Omtvedt, TN Wien, T Myran, K Sletten, G Husby	Amyloid	2004
Serum amyloid P component induces neuronal apoptosis and β-amyloid immunoreactivity Z Urbányi, L László, TB Tomasi, E Tóth, É Mekes, M Sass, T Pázmány	Brain Research	2003
Monoclonal Gammopathies and the Kidney G Touchard, P Aucouturier, O Hermine, P Ronco		2003
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis PN Hawkins	Current Opinion in Nephrology and Hypertension	2002
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis MB Pepys, J Herbert, WL Hutchinson, GA Tennent, HJ Lachmann, JR Gallimore, LB Lovat, T Bartfai, A Alanine, C Hertel, T Hoffmann, R Jakob-Roetne, RD Norcross, JA Kemp, K Yamamura, M Suzuki, GW Taylor, S Murray, D Thompson, A Purvis, S Kolstoe, SP Wood, PN Hawkins	Nature	2002
The Systemic and Local Acute Phase Response Following Acute Brain Injury DC Wilcockson, SJ Campbell, DC Anthony, VH Perry	Journal of Cerebral Blood Flow & Metabolism	2002
Diagnostic tools for amyloidosis E Hachulla, G Grateau	Joint Bone Spine	2002
Moyens paracliniques du diagnostic des amyloses É Hachulla, G Grateau	Revue du Rhumatisme	2002
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein JD Gillmore, LB Lovat, MR Persey, MB Pepys, PN Hawkins	The Lancet	2001
Pathogenesis, diagnosis and treatment of systemic amyloidosis CM Dobson, RJ Ellis, AR Fersht, MB Pepys	Philosophical Transactions of The Royal Society B Biological Sciences	2001
Mécanismes de l'amylose et protéines impliquées H Lebrazi, E Hachulla, R Saile	La Revue de Médecine Interne	2000
Renal transplantation for amyloid end-stage renal failure-insights from serial serum amyloid P component scintigraphy JD Gillmore, S Madhoo, MB Pepys, PN Hawkins	Nuclear Medicine Communications	2000
Stratégie diagnostique des amyloses G Grateau, H Lebrazi, S Valleix, E Hachulla, M Delpech, R Saïle	La Revue de Médecine Interne	2000
Human Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum WL Hutchinson, E Hohenester, MB Pepys	Molecular Medicine	2000
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction M Griselli, J Herbert, WL Hutchinson, KM Taylor, M Sohail, T Krausz, MB Pepys	Journal of Experimental Medicine	1999
C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction M Griselli, J Herbert, WL Hutchinson, KM Taylor, M Sohail, T Krausz, MB Pepys	Journal of Experimental Medicine	1999
The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients LB Lovat, MR Persey, S Madhoo, MB Pepys, PN Hawkins	Gut	1998
Protein aggregation: folding aggregates, inclusion bodies and amyloid AL Fink	Folding and Design	1998
Amyloid P component. A critical review MB Pepys, DR Booth, WL Hutchinson, JR Gallimore, IM Collins, E Hohenester	Amyloid	1997
Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene M Botto, PN Hawkins, MC Bickerstaff, J Herbert, AE Bygrave, A Mcbride, WL Hutchinson, GA Tennent, MJ Walportz, MB Pepys	Nature Medicine	1997
Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearance GJ Clesham, DM Vigushin, PN Hawkins, MB Pepys, CM Oakley, P Nihoyannopoulos	The American Journal of Cardiology	1997
Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology SY Tan, A Irish, CG Winearls, EA Brown, PE Gower, EJ Clutterbuck, S Madhoo, JP Lavender, MB Pepys, PN Hawkins	Kidney International	1996
Diagnosis and treatment of primary amyloidosis E Pascali	Critical Reviews in Oncology/Hematology	1995
Imaging amyloidosis with radiolabelled SAP PN Hawkins, MB Pepys	European Journal of Nuclear Medicine	1995
Treatment of amyloidosis SY Tan, MB Pepys, PN Hawkins	American Journal of Kidney Diseases	1995
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis GA Tennent, LB Lovat, MB Pepys	Proceedings of the National Academy of Sciences	1995
A Novel Variant of Transthyretin, 59 Thr→Lys , Associated With Autosomal Dominant Cardiac Amyloidosis in an Italian Family DR Booth, SY Tan, PN Hawkins, MB Pepys, A Frustaci	Circulation	1995
The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo WL Hutchinson, GE Noble, PN Hawkins, MB Pepys	Journal of Clinical Investigation	1994
Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli MB Pepys, SE Booth, GA Tennent, PJ Butler, DG Williams	Clinical & Experimental Immunology	1994
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure MB Pepys, TW Rademacher, S Amatayakul-Chantler, P Williams, GE Noble, WL Hutchinson, PN Hawkins, SR Nelson, JR Gallimore, J Herbert	Proceedings of the National Academy of Sciences	1994
Proteoglycans, glycosaminoglycans and amyloid deposition JH Magnus, T Stenstad, G Husby	Baillière's Clinical Rheumatology	1994
Diagnosis and monitoring of amyloidosis PN Hawkins	Baillière's Clinical Rheumatology	1994
Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Pepys MB, Booth SE, Tennent GA, Butler PJ, Williams DG	Clinical & Experimental Immunology	1994
Labeling of cerebral amyloid in vivo with a monoclonal antibody. Walker LC, Price DL, Voytko ML, Schenk DB	Journal of Neuropathology and Experimental Neurology	1994
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis G Holmgren, L Steen, O Suhr, BG Ericzon, CG Groth, O Andersen, BG Wallin, A Seymour, S Richardson, PN Hawkins, MB Pepys	The Lancet	1993
On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component T Stenstad, JH Magnus, K Syse, G Husby	Clinical & Experimental Immunology	1993
Studies of the structure and binding properties of hamster female protein GA Tennent, ML Baltz, GD Osborn, PJ Butler, GE Noble, PN Hawkins, MB Pepys	Immunology	1993
Severe dominant dystrophic epidermolysis bullosa complicated by systemic amyloidosis MG Dunnill, RB Mallett, PN Hawkins, PJ Vallance, RA Marsden	British Journal of Dermatology	1993
Serum amyloid p component scintigraphy and turnover studies for diagnosis and quantitative monitoring of aa amyloidosis in juvenile rheumatoid arthritis PN Hawkins, S Richardson, DM Vigushin, J David, CR Kelsey, RE Gray, MA Hall, P Woo, JP Lavender, MB Pepys	Arthritis & Rheumatism	1993
Hamster female protein binding to chromatin, histones and DNA L Saunero-Nava, JE Coe, C Mold, TW du Clos	Molecular Immunology	1992
Induction in mice of human light-chain-associated amyloidosis A Solomon, DT Weiss, MB Pepys	The American Journal of Pathology	1992
Amyloid P component and the diagnosis of amyloidosis MB Pepys	Journal of Internal Medicine	1992
Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis PN Hawkins, GA Tennent, P Woo, MB Pepys	Clinical & Experimental Immunology	1991
Serum amyloid P component in chronic renal failure and dialysis SR Nelson, GA Tennent, D Sethi, PE Gower, FW Ballardie, S Amatayakul-Chantler, MB Pepys	Clinica Chimica Acta	1991
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component SR Nelson, PN Hawkins, S Richardson, MB Pepys, JP Lavender, D Sethi, PE Gower, CW Pugh, CG Winearls, DO Oliver	The Lancet	1991
Amyloidosis PN Hawkins	Blood Reviews	1988

Advertisement